Pivotree Inc. (CVE:PVT – Free Report) – Stock analysts at National Bank Financial lowered their FY2024 EPS estimates for Pivotree in a research report issued on Wednesday, November 13th. National Bank Financial analyst J. Shao now expects that the company will earn ($0.27) per share for the year, down from their previous estimate of ($0.22). The consensus estimate for Pivotree’s current full-year earnings is $0.08 per share. National Bank Financial also issued estimates for Pivotree’s FY2025 earnings at ($0.02) EPS.
Several other research analysts also recently weighed in on the company. Cormark downgraded Pivotree from a “buy” rating to a “market perform” rating in a research note on Thursday. Canaccord Genuity Group cut their price objective on shares of Pivotree from C$1.25 to C$1.00 in a research note on Thursday. Four investment analysts have rated the stock with a hold rating and one has given a buy rating to the company. According to data from MarketBeat.com, Pivotree presently has an average rating of “Hold” and a consensus price target of C$2.38.
Pivotree Trading Up 3.3 %
CVE PVT opened at C$0.93 on Monday. Pivotree has a 52 week low of C$0.88 and a 52 week high of C$2.20. The company has a 50 day moving average price of C$1.08 and a 200 day moving average price of C$1.24. The company has a quick ratio of 1.95, a current ratio of 2.80 and a debt-to-equity ratio of 0.73. The firm has a market cap of C$24.47 million, a PE ratio of -2.58 and a beta of 0.22.
About Pivotree
Pivotree Inc designs, integrates, deploys, and manages digital platforms in commerce, data management, and supply chain for retail and branded manufacturers in Canada and internationally. The company offers infrastructure deployment, data transaction, subscription license, system and application triage and support, configuration management, and security services, as well as provides web and application hosting services.
Recommended Stories
- Five stocks we like better than Pivotree
- 3 Tickers Leading a Meme Stock Revival
- Warren Buffett, Cathie Wood Own Nu Holdings, Should You?
- Differences Between Momentum Investing and Long Term Investing
- MercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?
- How to Use Stock Screeners to Find Stocks
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
Receive News & Ratings for Pivotree Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pivotree and related companies with MarketBeat.com's FREE daily email newsletter.